首页> 外文会议>International Symposium on Ocular Pharmacology and Therapeutics >Platelet-rich plasma autologous eyedrops and punctal plug occlusion for dry eye secondary to graft versus host disease
【24h】

Platelet-rich plasma autologous eyedrops and punctal plug occlusion for dry eye secondary to graft versus host disease

机译:富含血小板的等离子体自体眼镜和泪塞闭塞,用于移植物与宿主病

获取原文

摘要

The aim of this study is to evaluate the efficacy of platelet-rich plasma (PRP) autologous eyedrops obtained with PRF-Vivostat~R for the purpose of improving visual quality in patients with graft versus host disease (GVHD). Twelve eyes of 12 patients were treated with PRP eyedrops and punctal plug occlusion. Tear-BUT, Schirmer test, fluorescein staining, visual acuity and visual quality improved statically after treatment. No adverse effects were observed during the follow-up, no antibiotic prophylactic eyedrops were used. In conclusion, PRP eyedrops obtained with PRF-Vivostat~R improved visual quality scores, dry eye symptoms and visual complaining in our case series. Further studies are needed to confirm our results.
机译:本研究的目的是评估用PRF-Vivostat〜R获得的富含血小板的血浆(PRP)自体眼镜的疗效,以提高移植物与宿主疾病(GVHD)的患者的视觉质量。 12名患者的12只眼睛用PRP EyeDrops和泪塞闭塞治疗。泪 - 但是,奇力试验,荧光素染色,视力和视觉质量在治疗后静态改善。在随访期间没有观察到不良反应,没有使用抗生素预防性眼镜。总之,用Prf-Vivostat〜R获得的PRP EyeDrops改善了视觉质量评分,干眼症症状和视觉抱怨我们的案例系列。需要进一步研究来确认我们的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号